Trial Profile
Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies: a Clinical Phase I Trial
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 Mar 2019
Price :
$35
*
At a glance
- Drugs Verteporfin (Primary) ; Cisplatin
- Indications Age-related macular degeneration; Central serous chorioretinopathy; Choroidal neovascularisation
- Focus Adverse reactions
- 18 Mar 2019 Status changed from recruiting to discontinued.
- 14 Mar 2016 New trial record